Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.

Gelijkaardige items

• Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.
  door: Brendan D. Looyenga, et al.
  Gepubliceerd in: (2014-01-01)
• Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
  Gepubliceerd in: (2014-01-01)
• STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma.
  door: Brendan D Looyenga, et al.
  Gepubliceerd in: (2012-01-01)
• The Role of gp130 Cytokines in Tuberculosis
  door: Kristina Ritter, et al.
  Gepubliceerd in: (2020-12-01)
• Cytokine Receptor-like Factor 1 (CRLF1) and Its Role in Osteochondral Repair
  door: Fenglin Zhang, et al.
  Gepubliceerd in: (2024-04-01)